Test Code SOFT: Z1000 Amino Acids, Quantitative, Plasma
Additional Codes
Ordering Mnemonic | Mayo Test ID |
---|---|
EPIC NAME: MISC. LAB TEST | AAQP |
EPIC CODE: LAB000
Reporting Name
Amino Acids, QN, PUseful For
Evaluating patients with possible inborn errors of metabolism using plasma specimens
May aid in evaluation of endocrine disorders, liver diseases, muscle diseases, neoplastic diseases, neurological disorders, nutritional disturbances, kidney failure, and burns
Monitoring of patients treated for various inborn errors of metabolism or other causes of amino acid imbalances
Testing Algorithm
Testing includes quantitation of the following amino acids: taurine, threonine, serine, asparagine, glutamic acid, glutamine, proline, alanine, citrulline, alpha-amino-n-butyric acid, valine, cystine, methionine, isoleucine, leucine, tyrosine, phenylalanine, beta-alanine, ornithine, lysine, histidine, argininosuccinic acid, allo-isoleucine, arginine, hydroxyproline, glycine, aspartic acid, ethanolamine, sarcosine, 1-methylhistidine, 3-methylhistidine, homocitrulline, alpha-aminoadipic acid, gamma-amino-n-butyric acid, beta-aminoisobutyric acid, hydroxylysine, cystathionine, and tryptophan.
For more information see Epilepsy: Unexplained Refractory and/or Familial Testing Algorithm.
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Portions of this test are covered by patents held by Quest Diagnostics
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
PlasmaOrdering Guidance
Body fluids are not acceptable specimens for this test.
For testing urine specimens, order AAPD / Amino Acids, Quantitative, Random, Urine.
For testing spinal fluid specimens, order AACSF / Amino Acids, Quantitative, Spinal Fluid.
Additional Testing Requirements
Not all patients with homocystinuria/homocystinemia will be detected by this assay. For quantitation of total homocysteine, order CMMPP / Cobalamin, Methionine, and Methylmalonic Acid Pathways, Plasma or HCYSP / Homocysteine, Total, Plasma in conjunction with this amino acids profile.
Shipping Instructions
Necessary Information
1. Patient's age is required.
2. Include family history, clinical condition (asymptomatic or acute episode), diet, and drug therapy information.
Specimen Required
Patient Preparation: Patient should fast overnight (4 hours minimum); infants should have specimen collected before next feeding (2-3 hours without total parenteral nutrition if possible).
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Green top (sodium heparin)
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Collect specimen and place on wet ice. Note: Thrombin-activated tubes should not be used for collection.
2. Centrifuge immediately or within 4 hours of collection if the specimen is kept at refrigerated temperature.
3. Being careful to ensure that no buffy coat is transferred, aliquot plasma into a plastic vial and freeze.
Specimen Minimum Volume
0.3 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma | Frozen | 14 days |
Reject Due To
Gross hemolysis | OK |
Gross lipemia | OK |
Gross icterus | OK |
Special Instructions
Reference Values
Amino acids |
Age groups |
||
<24 months |
2-17 years |
≥18 years |
|
Taurine (Tau) |
31-354 |
32-181 |
21-123 |
Asparagine (Asn) |
18-94 |
25-80 |
23-94 |
Serine (Ser) |
59-224 |
53-166 |
55-146 |
Hydroxyproline (Hyp) |
<121 |
<73 |
<38 |
Glycine (Gly) |
80-500 |
80-500 |
80-500 |
Glutamine (Gln) |
356-857 |
353-790 |
447-774 |
Aspartic Acid (Asp) |
<48 |
<17 |
<13 |
Ethanolamine (EtN) |
<70 |
<30 |
<20 |
Histidine (His) |
46-147 |
56-119 |
61-120 |
Threonine (Thr) |
49-358 |
48-205 |
73-325 |
Citrulline (Cit) |
8-42 |
12-44 |
18-57 |
Sarcosine (Sar) |
<20 |
<20 |
<20 |
b-Alanine (bAla) |
<36 |
<36 |
<36 |
Alanine (Ala) |
139-474 |
144-557 |
200-579 |
Glutamic Acid (Glu) |
28-376 |
16-182 |
13-148 |
1-Methylhistidine (1MHis) |
<12 |
<12 |
<12 |
3-Methylhistidine (3MHis) |
<11 |
<30 |
<35 |
Argininosuccinic Acid (Asa) |
<5 |
<5 |
<5 |
Homocitruline (Hcit) |
<5 |
<2 |
<2 |
Arginine (Arg) |
28-164 |
28-156 |
45-144 |
a-Aminoadipic Acid (Aad) |
<4 |
<4 |
<4 |
g-Amino-n-butyric Acid (GABA) |
<4 |
<4 |
<4 |
b-Aminoisobutyric Acid (bAib) |
<9 |
<5 |
<5 |
a-Amino-n-butyric Acid (Abu) |
<40 |
<40 |
<40 |
Hydroxylysine (Hyl) |
<4 |
<4 |
<4 |
Proline (Pro) |
102-342 |
99-389 |
107-383 |
Ornithine (Orn) |
32-171 |
32-148 |
39-154 |
Cystathionine (Cth) |
<4 |
<4 |
<4 |
Cystine (Cys) |
6-131 |
3-151 |
8-310 |
Lysine (Lys) |
83-304 |
61-291 |
105-335 |
Methionine (Met) |
12-57 |
13-41 |
13-40 |
Valine (Val) |
94-382 |
111-367 |
134-357 |
Tyrosine (Tyr) |
27-188 |
36-133 |
36-113 |
Isoleucine (IIe) |
23-149 |
26-150 |
29-153 |
Leucine (Leu) |
59-213 |
51-216 |
79-217 |
Phenylalanine (Phe) |
36-105 |
38-116 |
45-106 |
Tryptophan (Trp) |
12-103 |
21-114 |
21-108 |
Alloisoleucine (Allolle) |
<5 |
<5 |
<5 |
All results reported in nmol/mL
Day(s) Performed
Monday through Friday
CPT Code Information
82139
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
AAQP | Amino Acids, QN, P | 35083-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
3570 | Interpretation (AAQP) | 49247-0 |
3512 | Taurine | 20657-3 |
3517 | Asparagine | 20638-3 |
3516 | Serine | 20656-5 |
34458 | Hydroxyproline | 20647-4 |
3522 | Glycine | 20644-1 |
3518 | Glutamine | 20643-3 |
34459 | Aspartic Acid | 20639-1 |
34460 | Ethanolamine | 26608-0 |
3535 | Histidine | 20645-8 |
3515 | Threonine | 20658-1 |
3521 | Citrulline | 20640-9 |
34461 | Sarcosine | 26613-0 |
3532 | Beta-Alanine | 26604-9 |
3523 | Alanine | 20636-7 |
3520 | Glutamic Acid | 20642-5 |
34453 | 1-Methylhistidine | 20633-4 |
34454 | 3-Methylhistidine | 20635-9 |
32341 | Argininosuccinic Acid | 32227-1 |
34456 | Homocitrulline | 55876-7 |
3536 | Arginine | 20637-5 |
34450 | Alpha-aminoadipic Acid | 26600-7 |
34463 | Gamma-amino-n-butyric Acid | 26609-8 |
34452 | Beta-aminoisobutyric Acid | 26605-6 |
3524 | Alpha-amino-n-butyric Acid | 20634-2 |
34464 | Hydroxylysine | 26610-6 |
3519 | Proline | 20655-7 |
3533 | Ornithine | 20652-4 |
34451 | Cystathionine | 26607-2 |
3526 | Cystine | 22672-0 |
3534 | Lysine | 20650-8 |
3527 | Methionine | 20651-6 |
3525 | Valine | 20661-5 |
3530 | Tyrosine | 20660-7 |
3528 | Isoleucine | 20648-2 |
3529 | Leucine | 20649-0 |
3531 | Phenylalanine | 14875-9 |
34465 | Tryptophan | 20659-9 |
32347 | Allo-isoleucine | 22670-4 |
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Disease States
- Alkaptonuria
- Homocystinuria
Clinical Information
Amino acids are the basic structural units that comprise proteins and are found throughout the body. Many inborn errors of amino acid metabolism, such as phenylketonuria and tyrosinemia, have been identified. Amino acid disorders can manifest at any age, but most become evident in infancy or early childhood. These disorders result in the accumulation or the deficiency of 1 or more amino acids in biological fluids, which leads to the clinical signs and symptoms of the specific amino acid disorder.
The clinical presentation is dependent upon the specific amino acid disorder. In general, affected patients may experience failure to thrive, neurologic symptoms, digestive problems, dermatologic findings, and physical and cognitive delays. If not diagnosed and treated promptly, amino acid disorders can result in intellectual disabilities and, possibly, death.
Treatment for amino acid disorders includes very specific dietary modifications. Nonessential amino acids are synthesized by the body, while essential amino acids are not and must be obtained through an individual's diet. Therapeutic diets are coordinated and closely monitored by a dietician or physician. They are structured to provide the necessary balance of amino acids with particular attention to essential amino acids and those that are abnormal in a particular disorder. Patients must pay close attention to the protein content in their diet and generally need to supplement with medical formulas and foods. Dietary compliance is monitored by periodic analysis of plasma amino acids.
In addition, plasma amino acid analysis may have clinical importance in the evaluation of several acquired conditions, including endocrine disorders, liver diseases, muscle diseases, neoplastic diseases, neurological disorders, nutritional disturbances, kidney failure, and burns.
Interpretation
When no significant abnormalities are detected, a simple descriptive interpretation is provided. When abnormal results are detected, a detailed interpretation is given, including an overview of the results and their significance, a correlation to available clinical information, elements of differential diagnosis, recommendations for additional biochemical testing, and in vitro confirmatory studies (enzyme assay, molecular analysis), name and phone number of key contacts who may provide these studies, and a phone number to reach one of the laboratory directors in case the referring physician has additional questions.
Cautions
Reference values are for fasting patients.
Patients with phenylketonuria (PKU) who are treated with pegvaliase-pqpz (Palynziq) may have false low phenylalanine concentrations due to persistent activity in collected blood specimens.
This assay does not measure total homocysteine. If relevant disorders are considered, also order CMMPP / Cobalamin, Methionine, and Methylmalonic Acid Pathways, Plasma or HCYSP / Homocysteine, Total, Plasma analysis.
Clinical Reference
1. Part 8: Amino Acids. In: Valle DL, Antonarakis S, Ballabio A, Beaudet AL, Mitchell GA. eds. The Online Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, 2019. Accessed October 24, 2024 Available at https://ommbid.mhmedical.com/book.aspx?bookID=2709#225069340
2. Pasquali M, Longo N: Amino acids. In: Blau N, Dionisi Vici C, Ferreira CR, Vianey-Saban C, van Karnebeek CDM, eds. Physician's Guide to the Diagnosis, Treatment and Follow-up of Inherited Metabolic Diseases. 2nd ed. Springer-Verlag; 2022:41-50
Method Description
Quantitative analysis of amino acids is performed by liquid chromatography tandem mass spectrometry (LC-MS/MS). Patient samples are combined with isotopically labeled internal standard. Following protein precipitation, the supernatant is subjected to hydrophilic interaction liquid chromatography for the separation of isomers with MS/MS detection of the underivatized amino acids.(Unpublished Mayo method)
Report Available
3 to 5 daysSpecimen Retention Time
2 weeksForms
If not ordering electronically, complete, print, and send a Biochemical Genetics Test Request (T798) with the specimen.